| GTO ID | GTC0365 |
| Trial ID | NCT03093350 |
| Disease | Breast Cancer |
| Altered gene | TAA |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | TAA TCR-T cells |
| Phase | Phase2 |
| Recruitment status | Active, Not Recruiting |
| Title | Tumor Associated Antigen (TAA) Specific Cytotoxic T Lymphocytes Administered in Patients With Breast Cancer |
| Year | 2017 |
| Country | United States |
| Company sponsor | Baylor College of Medicine |
| Other ID(s) | H-39209 TACTIC |
| Cohort 1 | |||||||||||||||
|
|||||||||||||||